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Introduction
Since obesity and many other weight-related disorders 
have reached epidemic levels, there is a large interest in 
the causes of excess body weight as well as various disor-
ders that share this specific symptom. The FTO (Fat mass 
and obesity-associated protein) gene, which was identified 
as one of the possible genetic triggers, is a large gene con-
taining nine exons that span over 400 kb on the long arm 
of chromosome 16 at position 12.2, and encodes for 2-oxo-
glutarate-dependent dioxygenase which functions in the 
repair of alkylated DNA and RNA by oxidative demethyl-
ation. It was first identified in the mouse genome on chro-
mosome 8, and is strongly conserved across various ver-
tebrate species1-5. FTO was shown to act as a demethylase 
with a strong preference for 3meU (methyluracil) and 
3meT (mononucleotide 3-methylthymidine) in single-
stranded RNA and DNA, respectively6. In addition, the 
gene plays an important role in global metabolism and 
maintaining homeostasis, and is known to be unequivo-
cally associated with adiposity and body fat accumulation 
control, as well as the control of adipocyte differentiation 
into white or brown fat cells7. FTO variants can interact 
with IRX3 (Iroquois homeobox 3) and even cause an in-
crease in IRX3 and IRX5 (Iroquois homeobox 5) expres-
sion during adipocyte differentiation8.
The FTO gene has 68 identified single nucleotide poly-
morphisms (SNPs)9. The FTO rs9939609 SNP is one of 
the ten SNPs in the first intron of the FTO gene, which 
was found to be associated with increased weight, raised 
body mass index (BMI) and related traits7. The FTO 
rs9939609 SNP has two alleles, T (wild-type) and A (mu-
tant), which were shown to be associated with the develop-
ment of obesity10.
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The link between FTO and eating disorders and 
type 2 diabetes mellitus
Type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) susceptibility genes 
and multiple SNPs located in the first intron of FTO were 
identified to be associated with T2DM in 20077, which led 
to a number of studies examining the effect of FTO SNPs 
on this and related conditions.
The rs9939609 SNP was found to be connected to an 
increased risk of T2DM, although this influence could also 
be explained by its effect on BMI in affected and unaf-
fected individuals11, since FTO was also found to influence 
appetite and food intake12. Furthermore, Gerken et al. 
suggested that, since present particularly in hypothalam-
ic nuclei governing energy balance, FTO mRNA levels in 
the arcuate nucleus might be regulated by feeding and 
fasting6. It has also been reported that FTO SNPs are 
associated with insulin resistance and that association 
can be observed even after the adjustment of BMI13.
The function of the FTO protein product has not been 
completely understood yet. Most studies are association 
studies, and mechanisms of relations between gene vari-
ants and traits remain obscure14. Numerous studies con-
firmed that the FTO genotype has an impact on BMI, 
which in turn has an effect on metabolic traits. However, 
there is still a lack of linkage between the genotype and 
the resulting metabolic trait. 
A recent study depicted that the FTO gene has a rapid 
turnover in the pancreatic β cells involved in the regula-
tion of insulin secretion under glucose stimulation15. Ad-
ditionally, according to the same study, FTO plays an 
important role in the function regulation of pancreatic β 
cells. However, the functional role of FTO in pancreatic β 
cells and related molecular mechanism are still unclear.
As the strongest common genetic determinants of adi-
posity, FTO variants partially act by influencing dopami-
nergic signaling in the brain and promote increased food 
intake16. The FTO A allele is linked to central insulin resistance, 
and peripheral insulin sensitivity regulation is controlled by cen-
tral insulin17. Dopamine neurons also express FTO proteins and 
inactivation of the FTO gene impairs dopamine receptor 
type 2 (D2R) and type 3 (D3R; collectively, ‘D2-like 
receptor’)-dependent control of neuronal activity and be-
havioral responses18.
There appears to be an interaction between FTO and 
ANNK1 polymorphisms that are responsible for midbrain 
activity during reward learning as both FTO and ANKK1 
confer risk for obesity by their influence on D2 receptors19. 
ANKK1 indicates reduced D2 receptor availability, which 
was shown to lead to an FTO variation-related increase 
in body fat and waist circumference, as well as reduced 
peripheral insulin sensitivity16. This event confers an in-
crease in the risk of obesity in the presence of any of the 
two risk alleles.
Eating disorders  
FTO was recently identified as a potential candidate 
for the molecular association with eating disorders (ED). 
A study published in 2017 suggests that individuals with 
the A allele are more likely to develop ED or to express 
emotional eating8,20. The two FTO SNPs assumed to have 
the largest effect on BMI variations between individuals 
are rs99396097 and rs993050621. The recent genome-wide 
association study (GWAS) for BMI, which included data 
from up to 247,796 European individuals, found rs1558902 
to be the most significantly associated SNP (PGWAS < 
10−60)22.
FTO and polycystic ovary syndrome 
Polycystic ovary syndrome (PCOS) is frequently accom-
panied by insulin resistance and glucose intolerance23. In 
addition, 38% to 88% of women with PCOS are overweight 
or obese24. Consequently, T2DM and PCOS share common 
symptoms, which led to the investigation of the connection 
between FTO gene variants and individuals’ risks of PCOS. 
Recently published studies have shown that the FTO gene 
variants might have large effects on obesity, insulin resis-
tance and glucose intolerance among patients with PCOS 
phenotypes25,26. The association between FTO and PCOS, 
however, still remains unclear and decrease in severity of 
phenotypic manifestations of PCOS is often linked to BMI 
improvement with weight loss27. In a study completed in 
2014, Louwers et al. demonstrated a lack of connection be-
tween 12 BMI risk alleles and PCOS28.
The effect of FTO rs9939609 combined with MC4R 
rs17782313 has been discussed in relation to PCOS after 
Figure 1. A flowchart for systematic review
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studies on their effect on obesity29. A ten-kg weight differ-
ence was reported between AA and TT homozygotic PCOS 
carriers30. In addition, the FTO rs9939609 polymorphism 
was found to be significantly associated with the risk of 
PCOS in Asians and Caucasians31. Li et al. (2013) also 
found that the mutant allele A of rs9939609 leads to a 
higher risk of PCOS (Pcombined= 1.26E-11, ORs = 1.44; 
Pmeta= 6.89E-12), even after the adjustment for differ-
ences in BMI (P = 1.82E-6)32.
We have therefore aimed to collect previously published 
data regarding the mutant allele A in different regions 
around the world and to summarize them in the form of a 
systematic review in order to investigate whether T2DM 
and PCOS onset and increase in BMI might be related to 
rs9939609 genotype.
Materials and Methods
This review is based on research papers collected from 
relevant databases. Terms “FTO”, “SNP”, “diabetes”, “in-
sulin”, “resistance”, “PCOS”, “gene”, “variant”, “BMI”, and 
“hypothalamus”, were searched in PubMed and Research-
Figure 2. A graph depicting the frequencies of T and A alleles of FTO SNP rs9939609 in worldwide populations. Results were 
obtained from original research articles. Allele frequencies were found to be similarly abundant in Caucasian populations
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Gate with a focus on papers published from the period of 
2007 up to the end of November 2017. 
In order to analyze the abundance of the mutant FTO 
allele, the authors searched for genotyping data of par-
ticular populations in the articles. From 46 papers, 14 
studies concentrated on non-target SNPs or contained 
data which was not represented adequately for further 
analysis, and were eliminated as non-eligible studies. 
Therefore, a total of 32 studies were accepted for this re-
view. Data extraction was performed in order to investi-
gate the frequency of mutant alleles in specific regions. All 
selected articles provided data on the distribution of FTO alleles 
in the studied population. Exclusion and inclusion criteria are 
briefly explained in the Figure 1.
In order to investigate the possibility of FTO rs9939609 
being an indicator for mutant allele-related disorders, A 
allele distribution was compared among populations in the 
world and data was linked to associated disorders for par-
ticular populations. Participants in the included studies 
were patients with conditions compared to control healthy 
subjects, or overweight/obese individuals compared to un-
derweight/normal weight individuals. Different types of 
genotyping methods were used, such as Taqman allelic 
discrimination33,34, restriction enzyme length polymor-
phism (RFLP)35,36 with restriction enzyme ScaI37, TaqMan 
assays38-42, Qiagen32,40,43,44, tetra-primer amplification re-
fractory mutation system polymerase chain reaction 
(ARMS-PCR)45 or agarose gel electrophoresis46,47. For re-
sult generation, we used sample sizes, genotype frequen-
cies, allele frequencies, region and year of study publica-
tion. 
In the first data extraction, a total of 32 data sets were 
obtained. Reorganization of obtained data provided dis-
tinguished data sets according to investigated popula-
tions, regions, and mutant allele-associated disorders. 
Results are presented in graphical form.
Results and Discussion
Most association studies reporting the effects of FTO 
variants were concerned with the gene variant effects on 
obesity and PCOS. A summary of all performed studies is 
given in Table 1.
In order to investigate the possibility of FTO rs9939609 
being an indicator of mutant allele-related disorders, A 
allele distribution was compared among worldwide popu-
lations, and data was associated to the disorders of inter-
est in those same populations. The data extraction pro-
vided 32 cohorts with genotype and allele frequencies from 
a total of 24 different populations. The highest mutant 
allele A frequency (49.5%) was observed in a combined 
French and Romanian population study30. The lowest A 
allele frequency was reported in South Korean popula-
tions48 in a study conducted by Kim et al., followed by the 
Figure 3. All FTO allele frequencies were plotted together in the following graph, and present over 24 worldwide populations
Figure 4. Higher-than-average distribution of the mutant allele A 
throughout Europe. More specifically, Romania and Italy reveal 
a statistically significant association between investigated FTO 
related disorders and mutant allele A as the groups in these 
populations are rich in that allele.
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TABLE 1
AN OVERVIEW OF THE STUDIES ON FTO SNP RS9939609
Study population Scope Findings of interest Reference
UK Obese, UK Control ED UK children participated in research regarding food intake. They were 
genotyped for rs9939609 and their eating behavior was analyzed. There 
was no significant relation between FTO genotype and any physical 
activity characteristics. However, it was shown that A allele is likely 
affecting appetite.  
[34]
Czech Republic General Population PCOS Authors proposed that the FTO gene is associated with higher OGTT-
stimulated glycaemia and leptin levels besides obesity-related quantitative 
traits. In this study, samples of participants from the Czech Republic were 
included. The most present genotype in population was TA, and mutant 
allele frequency was 43.2%. 
[58] 
Retrieved 
from [30]
Mexico Nonobese, Mexico Class I/II 
Obese, Mexico Class III Obese, 
Mexico Obese Healthy, Mexico Non-
obese Healthy, Mexico T2DM, 
Mexico Healthy 
BMI Subcutaneous and visceral adipose tissue biopsies from class III obesity 
patients were investigated for FTO and ABCA1 mRNA expression. This 
was the first report giving evidence of FTO and ABCA1 variant interac-
tions affecting BMI. FTO and ABCA1 risk alleles revealed a lack of 
significant association with BMI or WC.
[38]
USA Caucasians  European 
Ancestry T2DM Male, USA 
Caucasians European Ancestry 
Healthy Male, USA Caucasians 
European Ancestry T2DM Female, 
USA Caucasians European 
Ancestry Healthy Female
Obesity Study subjects were genotyped for rs9939609 in a larger research cohort. 
Measurements also included plasma adiponectin and leptin for both 
diabetic men and women. The authors observed a decrease in the level of 
association between rs9939609 and BMI in individuals older than 65. 
[36]
Denmark Treatment Naïve, 
Denmark Caucasians, Denmark 
NGT, Denmark T2DM
T2DM Danish participants from five different study groups were genotyped for 
FTO rs9939609. It was confirmed that this variation is associated with 
T2DM even without BMI adjustment. 
[33]
France and Romania General 
Population
PCOS From a study completed by Wojciechowski (2012), combined genotypes of 
French and Romanian populations previously published in Attaoua (2008) 
were analyzed for a total of 189 genotypes.Attaoua (2008) reported very 
similar incidence in both wild and mutant alleles. The most present 
genotype was TA. Attaoua (2008) reported association between MetS and 
PCOS.
[59] 
Retrieved 
from [30]
China PCOS, China Control PCOS PCOS patients and healthy controls participated in this case-control 
association study of linkage between FTO rs9939609 and PCOS develop-
ment. The difference in allele frequencies between the groups was 
statistically significant with a higher frequency of mutant allele in the 
PCOS group. The mutant allele was found to influence PCOS development 
by causing an increase in the carrier’s BMI.
[50] 
Retrieved 
from [31]
Poland General Population PCOS PCOS patients were the subject of anthropometric measurement, euglycae-
mic–hyperinsulinaemic clamp, oral glucose tolerance tests and sex 
hormone assessments. The study group was also genotyped for 
the FTOrs9939609 polymorphism. The FTO gene risk variant seems to 
have more impact on obesity and related traits in patients with PCOS than 
in others.
[52]
Austria General Population PCOS The impact of FTO variants on metabolic and endocrine parameters in 
PCOS women were investigated in PCOS patients. Alongside genotyping, 
metabolic and hormonal measurements, oral glucose tolerance test, 
hirsutism score, and lipometry were performed. The A allele was associ-
ated with a significant increase in free testosterone, BMI, 2-hour glucose, 
1-hour insulin, and AUCins, as well as body fat percentage. The authors 
demonstrated that rs9939609 influences hyperandrogenemia and 
anthropometric parameters in women with PCOS.
[54]
UK combined OBB/UKBS, UK 
Control OBB, UK control UKBS, 
UK PCOS
PCOS This was a genetic association study of the FTO rs9939609 variant with 
case–control analyses conducted on UK PCOS patients. Authors 
provided the first report about predisposing variants to common obesity, 
which also may lead to PCOS, mediated through adiposity. Authors 
reported a significant association between FTO genotype and PCOS 
status.
[60]
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USA General Population, USA 
General population
PCOS Subjects from families having a history of PCOS had samples taken for 
genotyping of 15 gene polymorphisms. Transmission/disequilibrium test 
(TDT) was used to assess linkage between PCOS and gene variants. In the 
independent case-study, PCOS women and healthy women were also 
analyzed. SNPs in FTO seemed to be associated with BMI in patients with 
PCOS, but to the reproductive phenotypes of PCOS.
[39]
Malaysia Female, Malaysia Male Obesity The aim of this study was to analyze the association of rs9939609 and 
obesity among 9- to 12-year-old children in Malaysia. No association 
between FTO rs9939609 polymorphism and BMI categories (p=0.9014), 
WC (p=0.6828), body fat percentage (p=0.9011),or gender (p=0.3345) was 
confirmed. 
[61]
China Han PCOS, China Han 
Control
PCOS A two-staged study involving PCOS patients and controls from an earlier 
GWAS, and an independent group of PCOS patients and controls was 
investigated for the relation between PCOS development and FTO gene 
variants. The influence of the SNP study was confirmed in both obese and 
non-obese groups.
[32]
Spain General population Meta-
bolic 
distur-
bance
Patients subsequently treated with pegIFNα/RBV therapy participated in 
this cross-sectional study. The resultsimply that the subjects carrying the 
risky AT/AA genotype of rs9939609 had higher odds of metabolic distur-
bances and didnot successfully respond to HCV therapy.
[53]
India Obese, India Control T2DM The individuals were a subject of investigation of GSTM1, GSTT1 and 
FTO polymorphism association with T2DM. The authors suggested further 
research, as significant association between the condition and FTO 
variants was not found.
[35]
South Korea PCOS, South Korea 
Control
PCOS The objective of this study was to investigate the association between FTO 
polymorphism and PCOS in non-obese women. It was concluded that this 
gene variant affects the development of PCOS by acting to increase BMI, 
but that rs9939609 is not the main determinant for developing PCOS 
throughout the lifetime.
[48]
Pakistan Obese, Pakistan 
Overweight, Pakistan Normal, 
Pakistan Total
BMI To find if there is an association between FTO gene rs9939609 polymor-
phism and BMI status of Karachi adolescents, subjects were classified as 
either normal, overweight or obese. The results have shown that 59.3% 
tested individuals had genotype TT, 32.6% were heterozygous, and 7.3% 
had the AA genotype. The results confirmed an increased risk of obesity in 
adolescents with genotype AA.
[37]
China Zhejiang PCOS, China 
Zhejiang Control
PCOS This study, enrolling PCOS patients andcontrols, were looking for a link 
between FTOrs9939609 and MC4Rrs17782313 polymorphisms and PCOS 
and obesity-related traits. The effect of FTO rs9939609 variant on PCOS 
development was confirmed, although through major influence on BMI.
[29]
China Uygur T2DM, China Uygur 
Control
T2DM T2DM patients and healthy controls participated in this study to examine 
the correlation between FTO, T2DM and BMI. The authors concluded that 
A allele of rs8050136 and rs9939609 (both from FTO gene) may be 
associated with the T2DM and obesity prevalence.
[46]
Brazil Caucasians PCOS, Brazil 
Caucasian Control
PCOS The study included PCOS patients and women with regular ovulation 
cycles. The correlation of FTO SNPsrs9939609 and rs8050136 with PCOS 
incidence was not found, while the presence of the risk allele in both SNPs 
was associated with higher fasting glucose levels.
[55]
Germany West European Ancestry 
AVS Total, Germany West 
European Ancestry Control Total, 
Germany West European Ancestry 
AVS Male, Germany West 
European Ancestry Control Male, 
Germany West European Ancestry 
AVS Female, Germany West 
European Ancestry Control Female
AVS Impact of the FTO genotype was investigated in German patients with 
AVS and controls. The authors reported that association of rs9939609 with 
AVS was independent of BMI and other variables, such as diabetes 
mellitus.
[45]
Brazil  
General 
Population
Obesity In the cross-sectional study, samples from children at age between 7 and 
17 were genotyped for the study FTO SNP, along with recording informa-
tion on the family history of obesity. The results implied that children with 
AA genotype were overweight/obese in 57.4% of all cases. On the other 
hand, TA and TT had lower percentage of overweight/obese children (33.1% 
and 28.9%, respectively).
[43]
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Lithuania  
General  
Population
Obesity Lithuanian individuals between 25 and 64 years were genotyped for 
rs9939609 in order to investigate the association between genotypes and 
obesity, and metabolic syndromes. The study confirmed a relationship 
between AA gene variants and high BMI. 
[41]
Taiwan General Population Obesity rs9939609 genotyping was done on Taiwanese adults to show that the TT 
genotype is the most abundant (73.3%), while AA was present in 1.5% 
study participants. Results prove that the FTO rs9939609 SNP may be 
linked with the risk of obesity.
[40]
China Osteoporosis, China Control Osteopo-
rosis
Two FTO SNPs, rs7206790 and rs9939609, were analyzed in the study of 
osteoporosis risk. The osteoporosis patients and healthy controls were 
genotyped. It was shown that rs9939609 SNP does not relate to the risk of 
osteoporosis development during the lifetime.
[49]
Poland Nonobese Male, Nonobese 
Female
BMI FTO genotyping of non-obese Poles, 20 to 40 years of age, was performed 
to study four variants (rs9939609, rs9930506, rs1421085 and rs1121980). 
For rs9939609, both female and male Poles revealed the highest frequency 
of AT genotype, while AA genotype was the least abundant. No significant 
differences were found between fat distribution indicators related to the 
haplotypes of the FTO gene in individuals with normal BMI.
[44]
Romania Obese Female, Romania 
Obese Male
Obesity In order to detect if there is any association between FTO variants and 
anthropometric and metabolic characteristics, Romanian children (obese 
and non-obese), were tested for allele variants. The results confirmed a 
significant association between obesity and rs9939609 genotype. 
[51]
Poland Szczecin General Meta-
bolic 
disor-
ders
The study involved Caucasian men aged 50–75 years. Higher concentra-
tions of TCh and LDL were found in men with the FTO rs9939609 SNP, 
even though MetS, T2DM, HT, and obesity were not related to it.
[47]
North India T2DM, North India 
Control
Obesity Obese and non-obese individuals were genotyped for rs9939609, along 
with measurement of fasting glucose and insulin levels, lipid profile, 
percentage body fat, fat mass and fat free mass. Significant association 
between FTO rs9939609 and obesity defined by BMI was reported.
[57]
Italy Healthy Control, Italy Eating 
Disorders Bolumia, Italy Eating 
Disorders Aanorexia, Italy Eating 
Disorders Total
ED The authors proposed a model of genetic variant interaction with eating 
disorders. The ED patients and healthy control subjects were genotyped for 
SNP rs9939609 and mutant allele A was confirmed to be associated with a 
binge eating behavior.  
[8]
Egypt MetS, Egypt Control MetS This is the first study reporting rs9939609 as the genetic risk factor for 
metabolic syndrome in Egyptian populations. Individuals with risk 
genotype (AA) have significantly higher ALT levels, which remained 
significant after the correction for BMI and serum triacylglycerols. 
However, the result was not statistically significant following conservative 
Bonferroni correction. 
[42]
T2DM=Type 2 diabetes mellitus, FTO=Fat mass and obesity-associated protein, PCOS=Polycystic ovary syndrome, AVS=Aortic valve ste-
nosis, SNP=Single nucleotide polymorphism, BMI=Body mass index, WC=Wrist circumference, ALT=Alanine aminotransferase, 
HCV=Hepatitis C virus, ABCA1=ATP-binding cassette transporter, MetS=Metabolic syndrome, LDL=Low density lipoprotein, TCh=Total 
Cholesterol, HT= Hypertension, AUCins =Area under the curve insulin,TDT=Transmission/disequilibrium test, NEGR1=Neural growth 
regulator 1, MC4R=Melanocortin 4 receptor, ED=Eating disorders, TCF7L2=Transcription Factor 7 like 2, INSIG2=Insulin induced gene 2, 
IR=Insulin resistance
Chinese population29,32,49,50 and the Taiwanese popula-
tion40.
In the investigation of allele frequencies among the 
study populations (Figure 2), it was observed that the 
highest frequency of A allele is present in European popu-
lation8,13,30,33,41,44,45,47,51-54 , populations of European descent 
on other continents55 or in populations that are likely to be 
of European descent46.
In order to analyze A allele distribution in more depth, 
allele frequencies from different study cohorts were added 
together and joint results are presented in Figure 3. The 
allele distribution patterns imply that geographically close 
populations exhibit similar allele frequencies for 
rs9939609 SNP. Considering the fact that European pop-
ulations are rich in FTO allele A, those populations were 
extracted from the dataset and plotted on a separate 
graph. In this way, it has been shown that alleles T and A 
have similar distribution throughout Europe (Figure 4).
South Korean, Taiwanese, and Chinese populations 
have similar patterns of A allele distribution. On the oth-
er hand, Uygur population, even though settled in China, 
shows a higher incidence of the mutant allele (Figure 5). 
According to earlier research on the Uygur population 
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from China, this population truly differs from its neigh-
boring populations, as confirmed in the present study 
(Figures 5 and 6a) using the FTO SNP rs9939609. Dogan 
et al. (2014) analyzed Uygurs in a study of 46 worldwide 
populations on the basis of autosomal short tandem re-
peats (STRs) to confirm its uniqueness in the region56. On 
the other hand, it is interesting to note that Egyptian and 
Indian populations have similar frequencies of A and T 
alleles, while Pakistani population tends to differ from 
these two (Figure 6b). However, it was not feasible to as-
sess the allele frequency ratios in Egypt and its closest 
neighbors, as Egypt is the only population of Arabs ana-
lyzed in this study (Figure 6b).
Brazilians of European origin exhibit results similar 
to those from European and US populations36,55. In addi-
tion, it has been observed that Brazilian Caucasian sub-
population differs by 8.2% from other Brazilian popula-
tions in terms of mutant allele A frequency. The lowest 
incidence of FTO allele A in the American continent was 
observed in Mexico (Figure 7).
Figure 5. Uygur and Egyptian populations differ from their neighboring populations in terms of A allele frequency distribution.
Figure 6. (a) The distribution of rs9939609 alleles in Asian populations with a significant increase of mutant allele A frequency in 
Indian and Uygur populations. (b) The comparison of rs9939609 allelic frequencies in Egypt and Asian countries.
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The focus of extensive research has been the relation 
between rs9939609 and T2DM7,33,46,57. Numerous studies 
have been conducted on FTO resulting in confirmed effects 
of gene variants on weight and BMI. A limitation of the 
present study is that data on FTO variants and their as-
sociation with T2DM were obtained from only four popula-
tions, namely Denmark, US Caucasian, Uygur, and North 
Indian. However, it was observed that allele A frequencies 
were similar in the T2DM groups and in control groups in 
all populations (Figure 8). In Denmark, the T2DM group 
had a 6.3% higher frequency of allele A when compared to 
the control. The mutant allele was more prevalent than 
wild-type allele T in the other three populations with a 
frequency difference of 4.4%, 3% and 0.5% in Uygur, Indian 
and US Caucasian populations, respectively (Figure 8).
Despite the fact that the overall frequency of allele A is 
rather low in Chinese population, PCOS patients from the 
same country tend to have a significant increase in the 
frequency of this allele. On the other hand, Brazilian popu-
lations have a relatively high allele A frequency, however 
Figure 7. The Mexican population has the lowest incidence of 
mutant FTO allele A in the Americas. Also, a difference in 
allele frequency between general Brazilian populations and 
Caucasian Brazilians and Europeans settled within the US has 
been observed.
Figure 8. Only four studies investigating the association 
between FTO SNP and T2DM fulfilled the inclusion criteria for 
the present meta-analysis and were therefore included in the 
study. In all four populations, dramatic differences in allele 
frequencies between control samples and patients were not 
observed.
Figure 9. In terms of the relations between PCOS and allele A 
of the FTO polymorphism, China has the most pronounced 
differences between patients and controls. The remaining three 
populations do not reveal any significant differences.
Figure 10. Although differences in allele A frequency has been 
noted between obese persons and controls in all three popula-
tions, it is important to note that T2DM frequency positively 
correlates with allele frequency as well, thus making it harder 
to generate final conclusions on FTO-obesity association.
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the difference between PCOS patients and controls is far 
less pronounced than in Chinese population (Figure 9).
Villalobos-Comparán et al. (2008) concluded that 
rs9939609 has been associated only with class III obesity 
and not with overall obesity or BMI in admixed Mexican 
adults38. The data available for the present analysis al-
lowed the comparison of obese individuals with controls 
in only three populations (UK, Mexican, and Indian)34,38,57. 
On the basis of this limited dataset, it has been concluded 
that the obese and non-obese groups within the study pop-
ulations positively correlate with A allele frequency in 
those populations. The most prominent difference in allele 
A frequency between obese and non-obese individuals was 
observed in the UK with allele A being 14.69% more preva-
lent in obesity group. 
Conclusions and Future Perspectives
The main objective of the present study was to collect 
and discuss previously published data on FTO SNP 
rs9939609, which has been associated with weight-relat-
ed health conditions. The results of original studies show 
a higher incidence of mutant A allele in European popula-
tions, as well as in populations of European origin inhab-
iting other continents when compared to the other regions 
of the world. In addition, it has been found that the fre-
quency of the mutant allele of this polymorphism posi-
tively correlates with increased BMI in study participants. 
Other conditions that were suspected of being associated 
with rs9939609 are PCOS and T2DM. However, as obe-
sity is usually one of the most prominent symptoms of both 
PCOS and T2DM, there is a necessity of normalizing pa-
tients’ data according to BMI. In addition, there is a need 
for selecting patients and healthy controls with similar 
demographic and other parameters in larger study co-
horts, which would enable researchers to follow the asso-
ciation between FTO polymorphism and a single condi-
tion. This is especially true for Arabic populations, as 
studies on these populations are scarce in current litera-
ture.
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FREDRIKSSON R, HÄGGLUND M, OLSZEWSKI PK, STEPHANS-
SON O, JACOBSSON JA, OLSZEWSKA AM, SCHIÖTH, HB, Endocri-
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DESETLJEĆE ZAJEDNIČKOG FTO-A RS9939609 POLIMORFIZAM: SUSTAVNI PREGLED
S A Ž E T A K
Nekoliko asocijacijskih studija koje se fokusiraju na polimorfizme FTO gena su objavljene u proteklih godina; međutim, 
povezanost između stanja vezanih s FTO-om i varijante gena FTO-a ostaje neobjašnjena. Populacijska genetika i asoci-
jacijske studije različitih populacija pružaju vrijedan alat za daljnja istraživanja. Stoga je cilj ovog sustavnog pregleda 
sažeti sadašnje znanje o FTO SNP rs9939609 i njegovu povezanost s vjerojatno vezanim uvjetima. Istraživanje je obuh-
vatilo izvorne istraživačke članke prikupljene iz baza podataka PubMed i ResearchGate koje su objavljene u razdoblju 
od 2007. do studenog 2017., a koje pružaju informacije o frekvenciji rs9939609 mutantne alele i njegovoj vjerojatnijoj 
povezanosti sa svim uvjetima za koje se sumnja da su povezani s mutantnim alelom. Podaci o genotipovima su ekstra-
hirani i analizirani, a nedostajući podaci dobiveni su iz sekundarnih izvora. Kratki sažeci relevantnih studija iz pri-
marnih izvora organizirani su u tablici pregleda. Rezultati sustavnog pregleda upućuju na to da je mutantni alel A 
najčešći u europskim populacijama i najrijeđi na Dalekom istoku. Nadalje, zaključeno je da je alel A dobar alat za 
predviđanje povećanog rizika od povišenog BMI-a kod osobe koja ga nosi, kao i da se alel A treba dalje analizirati kao 
mogući marker rizika za dijabetes melitus tip 2 te razvoj sindroma policističnih jajnika.
